Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Neoplasm Metastasis 12Pain 10Bone Neoplasms 8Breast Neoplasms 7Humoral Hypercalcemia Of Malignancy 2Prostatic Neoplasms 1Osteoporosis 1Multiple Myeloma 1Lung Neoplasms 1Hematologic Neoplasms 1Esophageal Neoplasms 1Clear-cell metastatic renal cell carcinoma 1Carcinoma, Squamous Cell 1Carcinoma, Renal Cell 1Breast Neoplasms, Male 1Bone Diseases, Metabolic 1Adenocarcinoma 1

Interventions

Cyclophosphamide 87fludarabine 77fludarabine phosphate 45Tacrolimus 45Whole-Body Irradiation 42Mycophenolic Acid 42Busulfan 35Melphalan 32Antilymphocyte Serum 24Methotrexate 23thymoglobulin 22Standard of Care 22Rituximab 22venetoclax 20Thiotepa 20Sirolimus 20Azacitidine 20Stem Cell Transplantation 18Granulocyte Colony-Stimulating Factor 18Practice Guidelines as Topic 17Cytarabine 16Bortezomib 16Nivolumab 15Filgrastim 15Specimen Handling 14Dexamethasone 14Blood Specimen Collection 14Cyclosporine 13Surveys and Questionnaires 12Mesna 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hematologic Neoplasms × Ibandronic Acid × Clear all
NCT00824993 2018-09-13

Prevention of Osteoporosis in Bone Marrow Transplantation (BMT) Patients

M.D. Anderson Cancer Center

Phase 3 Completed
78 enrolled 7 charts
Other hematologic neoplasm

Bone Diseases, Metabolic, Osteoporosis, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡